Log In
Print
BCIQ
Print
Print this Print this
 

REGN727, SAR236553

Also known as: SAR236553/REGN727

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionHuman mAb targeting proprotein convertase subtilisin/kexin type 9 (PCSK9)
Molecular Target Proprotein convertase subtilisin/kexin type 9 (PCSK9)
Mechanism of ActionAntibody
Latest Stage of DevelopmentPhase III
IndicationHypercholesterolemia
Partner

Regeneron Pharmaceuticals Inc.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today